Search PubMed⌕ Search

Biomedical subjects

P Taylor

Publications and source records attributed to P Taylor.

At least 217 records · Page 12Linked to original sources

Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men.

Experimental and human epidemiologic data suggest a protective role for vitamin D in large bowel cancer. To investigate this association, we conducted a nested case-control study within a Finnish clinical trial cohort. Cases (n = 146) were participants diagnosed with primary adenocarcinoma of the large bowel. Controls were matched (2:1) to cases on age, date of baseline blood draw, and study clinic. Prediagnostic serum levels of the vitamin D metabolites, 25-hydroxyvitamin D (25-OH D), and 1,25-dihydroxyvitamin D (1,25-DIOH D) were used as primary exposure measures. The baseline geometric-mean serum level of 25-OH D was 11.6 percent lower in cases than in controls (12.2 cf 13.8 ug/l, P = 0.01) while serum levels of 1,25-DIOH D did not differ by case-control status. No association was seen between serum levels of 1,25-DIOH D and large bowel cancer risk. However, the estimated relative risk (RR) of large bowel cancer decreased with increasing level of serum 25-OH D and the association was more pronounced for rectal cancer (55 cases; RR by quartile = 1.00, 0.93, 0.77, 0.37; trend P = 0.06). Neither exclusion of early cases nor multivariate adjustment for potential confounders materially altered these estimates. There was no evidence of effect modification by level of 1,25-dihydroxyvitamin D or with other known risk-factors for large bowel cancer.

Adenocarcinoma↗

Paranasal sinusitis following allogeneic bone marrow transplant.

In attempt to identify major clinical features of paranasal sinusitis following allogeneic BMT, we reviewed 44 consecutive cases diagnosed at the Hammersmith Hospital between August 1993 and December 1995. All patients had symptoms and signs characteristic of sinusitis. Plain radiographs and/or CT scans revealed fluid levels in 86.4% of patients, opacification in 9.1%, and marked mucosal thickening in 4.5%. Two-thirds of patients were diagnosed within 120 days of BMT. The WBC was less than 1 x 10(9)/1 in 16.3% of patients, the neutrophil count was less than 0.5 x 10(9)/1 in 18.6%, and serum immunoglobulins were depressed (< 6.7 g/l) in 40.6%. Grade III-IV acute GVHD was present in 25.6% of patients and grade I-II in 66.7%; 68.6% developed chronic GVHD. There were 70.5% of patients receiving corticosteroids. Specific pathogens could not be identified in most cases. Pneumonia was present in 10 patients, seven of whom had Aspergillus species identified by bronchoalveolar lavage. Parainfluenza virus was isolated in three patients and Pseudomonas aeruginosa in two. Although all patients received antimicrobial therapy, 70.5% developed chronic sinusitis. Fatal complications did not occur. In 94 consecutive patients receiving allografts for CML during the period of study, WBC and neutrophil counts were lower 3 months post-BMT in patients who developed sinusitis (P < 0.02). Patients receiving higher doses of total body irradiation (13.2 and 14.4 Gy) had a greater probability of developing sinusitis (P = 0.023). Sinusitis occurred in only one of 37 patients receiving autologous transplants in the same period. Sinusitis is common following allogeneic BMT. Leukopenia is often present, but microbiological diagnosis is difficult, and progression to chronic sinusitis common.

Adolescent↗

Rate of seasonal spread of respiratory syncytial virus in a pediatric hospital.

The rate of nosocomial respiratory syncytial virus (RSV) infection was measured in a large pediatric hospital using an incidence density method. The at-risk days for nosocomial RSV were summed during a defined winter period in which there were 54 admissions with community-acquired RSV infection giving a rate of 2.9 cases per 1,000 at-risk days (95% confidence interval, 0.3-5.4 per 1,000).

Community-Acquired Infections↗

Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders.

Antibody-dependent cellular cytotoxicity (ADCC) is an important antiviral effector mechanism. ADCC to the protein encoded by the Epstein-Barr virus (EBV) BamHI A rightward open-reading frame-1 (BARF1) was studied by transducing Raji-tk- cells with the BARF1 gene using a retroviral expression vector. The transduced Raji cells expressed BARF1 on the cell surface, as determined by flow cytometry. Sera from chronic and acute infectious mononucleosis and nasopharyngeal carcinoma patients were found to contain antibodies that react with the BARF1 protein. When BARF1-expressing Raji cells were used as targets for ADCC, sera from several nasopharyngeal carcinoma patients demonstrated significant ADCC reactivity, whereas sera from healthy EBV-seronegative and -seropositive persons lacked such reactivity. BARF1-specific ADCC activity could be competitively inhibited with recombinant BARF1 protein. The level of anti-BARF1 antibody activity in sera of patients with EBV-associated diseases suggests that the BARF1 protein may serve as a target on EBV-infected cells for ADCC.

Acute Disease↗

Hair as a filler material for reconstructive or cosmetic surgery.

The purpose of this study was to investigate the possible use of hair as a filler material for reconstructive or cosmetic surgery. Many implant materials tested so far have proved to be of limited usefulness due to a lack of staying power or to fears of a host immune response, among other problems. In this study, pellets of rat hair were placed subcutaneously or beneath the pectoral muscle of Lewis rats (10 rats per group). A thin vascularized fibrous pouch containing inflammatory cells had formed around the hair pellet at 4 months. By 8 to 12 months, the hair had compacted, and the fibrous matrix of the pouch showed very few inflammatory cells surrounding the embedded hairs. There was no evidence of implant rejection, granuloma formation, or hair degradation up to 12 months after implantation. The results indicate that hair merits further study as a surgical implant material.

Animals↗

Experience of clinical use of the Odstock dropped foot stimulator.

The Odstock dropped foot stimulator (ODFS) is a simple functional electrical stimulation (FES) device for the correction of dropped foot. Improved reliability, fine control of stimulation parameters, and careful application and follow-up have let to 86% compliance. Data on 56 patients (50 patients with hemiplegia, 5 patients with multiple sclerosis, and 1 patient with spinal cord injury) who have used the system for between 6 and 18 months are presented and show a statistically significant increase in walking speed with the stimulator at 3 months of 14% (p < 0.001); decreased effort of walking, measured as physiological cost index (PCI), of 37% (p < 0.001); and statistically significant improvement in functional mobility tests and questionnaires. No statistically significant carryover was seen although 3 patients had sufficient improvement in active ankle control and gait parameters to no longer need the stimulator. Six patients who used the stimulator all day every day had a problem with skin irritation, which we have not yet been able to solve. Two patients discontinued use after experiencing increased spasticity in the calf.

Electric Stimulation Therapy↗

Users' views of a drop-in project for the homeless.

Homeless adults attending a drop-in voluntary project were approached to assess their views on the project, pathways into homelessness, physical and mental health needs and history of substance misuse. Over a six week period, 70 users were interviewed. Of these 54 (77%) were men and the rest women. Twenty five (35%) were living in insecure accommodation. A significant proportion 61% (43) acknowledged having suffered from emotional or mental health problems in the past and nearly half (47%) admitted to having received a psychiatric diagnosis. Nearly one third reported past criminal record. The use of substances (drugs and alcohol) was fairly common. There were no ethnic differences in the findings although the numbers from ethnic minorities remain small. This is not a typical homeless sample but the findings suggest vulnerability of such a group. The group was by and large satisfied with the open access and flexible approach of the project. The findings are discussed in relation to the acceptable services provided by voluntary organisations and suggestions made for further studies.

Adult↗

Quality of life of candidates for and recipients of heart transplants.

OBJECTIVE: To describe the quality of life (QOL) of candidates for and recipients of heart transplants over a five-year period. DESIGN: Descriptive, longitudinal. SETTING: Canadian university-affiliated tertiary care medical centre. PATIENTS: Sixty-five candidates for heart transplantation; after one year, six candidates were still awaiting transplantation; 42 patients received transplants and were included in the study six months post-transplant. OUTCOME MEASURES: Three measures of QOL were used: the Index of Well-Being, Cantril's Self-Anchoring Striving Scale and the "time-trade-off technique'. INTERVENTION: Data were collected before transplantation, six months post-transplantation, one year post-transplantation and annually for the next four years; for individuals who did not receive transplants, data were collected six months and one year after the first interview. MAIN RESULTS: QOL scores were considerably higher after than before transplantation, and compared favourably with norms for the general population. For 11 individuals who did not receive transplants, QOL remained low. QOL for heart transplant recipients was remarkably stable over the five-year study period. The major predictors of QOL for candidates awaiting transplantation were health status, outlook and ability to work. After transplantation, the major predictors of QOL were outlook, health status and employment status. CONCLUSIONS: There is evidence to suggest that QOL improves after heart transplantation, and that improvement is relatively stable over time. Further work is needed to identify the factors that could result in improvements in QOL.

Adult↗

Major grass pollen allergen Lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution.

BACKGROUND: Grass pollen allergens are known to be present in the atmosphere in a range of particle sizes from whole pollen grains (approx. 20 to 55 microns in diameter) to smaller size fractions < 2.5 microns (fine particles, PM25). These latter particles are within the respirable range and include allergen-containing starch granules released from within the grains into the atmosphere when grass pollen ruptures in rainfall and are associated with epidemics of thunderstorm asthma during the grass pollen season. The question arises whether grass pollen allergens can interact with other sources of fine particles, particularly those present during episodes of air pollution. OBJECTIVE: We propose the hypothesis that free grass pollen allergen molecules, derived from dead or burst grains and dispersed in microdroplets of water in aerosols, can bind to fine particles in polluted air. METHODS: We used diesel exhaust carbon particles (DECP) derived from the exhaust of a stationary diesel engine, natural highly purified Lol p 1, immunogold labelling with specific monoclonal antibodies and a high voltage transmission electron-microscopic imaging technique. RESULTS: DECP are visualized as small carbon spheres, each 30-60 nm in diameter, forming fractal aggregates about 1-2 microns in diameter. Here we test our hypothesis and show by in vitro experiments that the major grass pollen allergen, Lol p 1, binds to one defined class of fine particles, DECP. CONCLUSION: DECP are in the respirable size range, can bind to the major grass pollen allergen Lol p 1 under in vitro conditions and represent a possible mechanism by which allergens can become concentrated in polluted air and thus trigger attacks of asthma.

Air Pollution↗